Mount Sinai West
New York, 10019, United States
NCT Number: NCT06798753
Occlusion Balloon catheter provides the ability to occlude the exit of the kidney pelvis during percutaneous nephrolithotomy (PCNL) and potentially prevents the migration of stone fragments into the ureter. The necessity for it might be questioned during supine PCNL due to the upward oblique position of the kidney. The objective of the study is to compare the presence of ureteral stone fragments upon completion of supine PCNL with and without using an occlusion balloon catheter (OBC).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
New York, 10019, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The occlusion balloon catheter (OBC) is a type of ureteral catheter equipped with a small inflatable balloon at its tip. When inflated, the balloon can help prevent the migration of stone fragments.
The 5FR ureteral catheter (5FR-UC) is an open-ended small-caliber tube inserted at the beginning of PCNL to facilitate visualization of the collecting system using fluoroscopy and assist with renal access.
Time frame: During procedure, up to 5 hours
Endoscopic identification of ureteral stone fragments will be used to compare rate of ureteral stone fragments upon completion of PCNL while using OBC versus 5FR-UC.
Time frame: During procedure, up to 5 hours
Length of procedure is a common procedural outcome of endourologic procedures.
Time frame: During procedure, up to 5 hours
Number of participants with intraoperative complications, a common procedural outcome of endourologic procedures
Time frame: during procedure, up to 5 hours
Number of participants with stent placement during procedure
Icahn School of Medicine at Mount Sinai
Other
The Presence of Ureteral Calculi Upon Supine PCNL Completion: Occlusion Balloon Catheter Versus 5FR Ureteral Catheter
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02214836
Calculi, Female Urogenital Diseases
Seattle, Washington, United States
View Trial DetailsNCT07159035
Calculi, Female Urogenital Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT07377461
Calculi, Female Urogenital Diseases
Ashkelon, Israel
View Trial DetailsNCT01835600
Calculi, Female Urogenital Diseases
Shanghai, Shanghai Municipality, China
View Trial Details